rs12534093
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_006547.3(IGF2BP3):c.236+5127A>T variant causes a intron change. The variant allele was found at a frequency of 0.182 in 152,190 control chromosomes in the GnomAD database, including 2,890 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.18 ( 2890 hom., cov: 33)
Consequence
IGF2BP3
NM_006547.3 intron
NM_006547.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 3.65
Publications
44 publications found
Genes affected
IGF2BP3 (HGNC:28868): (insulin like growth factor 2 mRNA binding protein 3) The protein encoded by this gene is primarily found in the nucleolus, where it can bind to the 5' UTR of the insulin-like growth factor II leader 3 mRNA and may repress translation of insulin-like growth factor II during late development. The encoded protein contains several KH domains, which are important in RNA binding and are known to be involved in RNA synthesis and metabolism. A pseudogene exists on chromosome 7, and there are putative pseudogenes on other chromosomes. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.289 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.182 AC: 27736AN: 152072Hom.: 2891 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
27736
AN:
152072
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.182 AC: 27738AN: 152190Hom.: 2890 Cov.: 33 AF XY: 0.181 AC XY: 13435AN XY: 74394 show subpopulations
GnomAD4 genome
AF:
AC:
27738
AN:
152190
Hom.:
Cov.:
33
AF XY:
AC XY:
13435
AN XY:
74394
show subpopulations
African (AFR)
AF:
AC:
4757
AN:
41530
American (AMR)
AF:
AC:
2544
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
963
AN:
3472
East Asian (EAS)
AF:
AC:
62
AN:
5192
South Asian (SAS)
AF:
AC:
1455
AN:
4820
European-Finnish (FIN)
AF:
AC:
1799
AN:
10574
Middle Eastern (MID)
AF:
AC:
78
AN:
294
European-Non Finnish (NFE)
AF:
AC:
15529
AN:
68004
Other (OTH)
AF:
AC:
445
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1175
2350
3526
4701
5876
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
310
620
930
1240
1550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
504
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.